RGEN - Repligen Non-GAAP EPS of $0.91 beats by $0.20 revenue of $207.63M beats by $18.57M
- Repligen press release ( NASDAQ: RGEN ): Q2 Non-GAAP EPS of $0.91 beats by $0.20 .
- Revenue of $207.63M (+27.4% Y/Y) beats by $18.57M .
- FY2022 outlook : Total revenue is expected to be in the range of $790M-$810M, an increase from previous guidance of $770M-$800M vs. consensus of $787.73M; Gross margin is expected to be 57.5%-58.5% on both a GAAP and non-GAAP basis, an increase from previous guidance of 57%-58%; Adjusted diluted EPS is expected to be in the range of $3.13-$3.20, an increase from previous guidance of $3.07-$3.15 vs. consensus of $2.47.
For further details see:
Repligen Non-GAAP EPS of $0.91 beats by $0.20, revenue of $207.63M beats by $18.57M